
| December 31, 2025 | December 31, 2024 | |||||||||||||
| Assets | ||||||||||||||
| Current assets | ||||||||||||||
| Cash and cash equivalents | $ | 329,648 | $ | 196,589 | ||||||||||
| Short-term investments | 69,462 | — | ||||||||||||
Accounts receivable, net of allowances of $1,931 and $2,701, respectively | 280,161 | 278,582 | ||||||||||||
| Inventories, net | 210,739 | 216,472 | ||||||||||||
| Prepaid expenses | 19,500 | 20,203 | ||||||||||||
| Income tax receivable | 656 | 6,426 | ||||||||||||
| Other current assets | 41,080 | 48,697 | ||||||||||||
| Total current assets | 951,246 | 766,969 | ||||||||||||
Property, plant, and equipment, net of accumulated depreciation of $125,807 and $112,099, respectively | 164,560 | 160,377 | ||||||||||||
| Goodwill | 951,197 | 943,645 | ||||||||||||
| Trademark | 736,000 | 736,000 | ||||||||||||
| Customer relationships, net | 178,126 | 198,333 | ||||||||||||
| Other intangibles, net | 88,899 | 96,095 | ||||||||||||
| Other non-current assets | 80,956 | 89,205 | ||||||||||||
| Total assets | $ | 3,150,984 | $ | 2,990,624 | ||||||||||
Liabilities and Stockholders’ Equity | ||||||||||||||
| Current liabilities | ||||||||||||||
| Current portion of long-term debt | $ | 13,261 | $ | 13,991 | ||||||||||
| Accounts payable | 77,007 | 81,476 | ||||||||||||
| Accrued expenses and other liabilities | 224,222 | 217,242 | ||||||||||||
| Income taxes payable | 8,754 | 273 | ||||||||||||
| Total current liabilities | 323,244 | 312,982 | ||||||||||||
| Long-term debt, net | 943,547 | 950,562 | ||||||||||||
| Deferred tax liabilities, net | 227,449 | 239,111 | ||||||||||||
| Other non-current liabilities | 63,736 | 64,322 | ||||||||||||
| Total liabilities | 1,557,976 | 1,566,977 | ||||||||||||
Stockholders’ equity | ||||||||||||||
Preferred stock, $0.001 par value, 100,000,000 authorized, no shares issued or outstanding as of December 31, 2025 and December 31, 2024 | — | — | ||||||||||||
Common stock $0.001 par value, 750,000,000 authorized; 246,272,783 issued and 217,356,414 outstanding at December 31, 2025; 244,444,889 issued and 215,778,520 outstanding at December 31, 2024 | 247 | 245 | ||||||||||||
| Additional paid-in capital | 1,109,522 | 1,093,468 | ||||||||||||
Common stock in treasury; 28,916,369 and 28,666,369 at December 31, 2025 and December 31, 2024, respectively | (363,182) | (358,133) | ||||||||||||
| Retained earnings | 851,134 | 699,564 | ||||||||||||
Accumulated other comprehensive loss | (4,713) | (11,497) | ||||||||||||
Total stockholders’ equity | 1,593,008 | 1,423,647 | ||||||||||||
Total liabilities and stockholders’ equity | $ | 3,150,984 | $ | 2,990,624 | ||||||||||
| Three Months Ended | Year Ended | |||||||||||||||||||||||||
| December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||
| Net sales | $ | 349,375 | $ | 327,075 | $ | 1,122,155 | $ | 1,051,606 | ||||||||||||||||||
| Cost of sales | 180,093 | 173,781 | 583,465 | 564,630 | ||||||||||||||||||||||
| Gross profit | 169,282 | 153,294 | 538,690 | 486,976 | ||||||||||||||||||||||
| Selling, general and administrative expense | 67,021 | 58,548 | 246,892 | 217,147 | ||||||||||||||||||||||
| Research, development and engineering expense | 7,965 | 6,908 | 27,201 | 25,778 | ||||||||||||||||||||||
| Acquisition and restructuring related expense | 119 | 3,976 | 3,886 | 6,464 | ||||||||||||||||||||||
| Amortization of intangible assets | 6,874 | 7,375 | 27,461 | 28,800 | ||||||||||||||||||||||
| Operating income | 87,303 | 76,487 | 233,250 | 208,787 | ||||||||||||||||||||||
| Interest expense, net | 11,665 | 13,563 | 50,282 | 62,163 | ||||||||||||||||||||||
| Loss on debt extinguishment | — | — | — | 4,926 | ||||||||||||||||||||||
| Other expense (income), net | 327 | (495) | (1,669) | (2,484) | ||||||||||||||||||||||
| Total other expense | 11,992 | 13,068 | 48,613 | 64,605 | ||||||||||||||||||||||
| Income from operations before income taxes | 75,311 | 63,419 | 184,637 | 144,182 | ||||||||||||||||||||||
| Provision for income taxes | 6,901 | 8,686 | 33,067 | 25,527 | ||||||||||||||||||||||
| Net income | $ | 68,410 | $ | 54,733 | $ | 151,570 | $ | 118,655 | ||||||||||||||||||
| Earnings per share | ||||||||||||||||||||||||||
| Basic | $ | 0.32 | $ | 0.25 | $ | 0.70 | $ | 0.55 | ||||||||||||||||||
| Diluted | $ | 0.31 | $ | 0.25 | $ | 0.68 | $ | 0.54 | ||||||||||||||||||
| Weighted average common shares outstanding | ||||||||||||||||||||||||||
| Basic | 217,159,379 | 215,584,373 | 216,593,972 | 215,028,683 | ||||||||||||||||||||||
| Diluted | 222,531,701 | 221,872,482 | 222,225,777 | 221,370,188 | ||||||||||||||||||||||
Hayward Holdings, Inc. Consolidated Statements of Cash Flows (In thousands) | Year Ended | |||||||||||||
| December 31, 2025 | December 31, 2024 | |||||||||||||
| Cash flows from operating activities | ||||||||||||||
| Net income | $ | 151,570 | $ | 118,655 | ||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities | ||||||||||||||
| Depreciation | 22,835 | 20,078 | ||||||||||||
| Amortization of intangible assets | 34,451 | 35,783 | ||||||||||||
| Amortization of deferred debt issuance fees | 3,763 | 4,203 | ||||||||||||
| Stock-based compensation | 13,389 | 10,595 | ||||||||||||
| Deferred income taxes (benefit) | (7,751) | (10,514) | ||||||||||||
| Allowance for credit losses | (770) | (169) | ||||||||||||
| Loss on debt extinguishment | — | 4,926 | ||||||||||||
| (Gain) loss on sale/disposal of property, plant and equipment | 485 | (428) | ||||||||||||
| Changes in operating assets and liabilities | ||||||||||||||
| Accounts receivable | 5,056 | (7,260) | ||||||||||||
| Inventories | 11,780 | 4,330 | ||||||||||||
| Other current and non-current assets | 6,377 | (41,167) | ||||||||||||
| Accounts payable | (5,940) | 11,794 | ||||||||||||
| Accrued expenses and other liabilities | 20,789 | 61,242 | ||||||||||||
| Net cash provided by operating activities | 256,034 | 212,068 | ||||||||||||
| Cash flows from investing activities | ||||||||||||||
| Purchases of property, plant, and equipment | (28,715) | (22,371) | ||||||||||||
| Software development costs | (1,957) | (1,918) | ||||||||||||
| Cash paid for acquisition of businesses, net of cash acquired | — | (55,153) | ||||||||||||
| Cash paid for asset acquisitions | (3,643) | — | ||||||||||||
| Proceeds from sale of property, plant, and equipment | — | 311 | ||||||||||||
| Purchases of short-term investments | (69,462) | — | ||||||||||||
| Proceeds from short-term investments | — | 25,000 | ||||||||||||
| Net cash used in investing activities | (103,777) | (54,131) | ||||||||||||
| Cash flows from financing activities | ||||||||||||||
| Proceeds from issuance of long-term debt | — | 2,886 | ||||||||||||
| Payments of long-term debt | (12,810) | (138,638) | ||||||||||||
| Proceeds from issuance of short-term notes payable | — | 6,340 | ||||||||||||
| Payments of short-term notes payable | (2,169) | (6,463) | ||||||||||||
| Debt issuance costs | (1,579) | — | ||||||||||||
| Purchase of common stock | (5,049) | (378) | ||||||||||||
| Other, net | 761 | (537) | ||||||||||||
| Net cash used in financing activities | (20,846) | (136,790) | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 1,648 | (2,655) | ||||||||||||
| Change in cash and cash equivalents | 133,059 | 18,492 | ||||||||||||
| Cash and cash equivalents, beginning of period | 196,589 | 178,097 | ||||||||||||
| Cash and cash equivalents, end of period | $ | 329,648 | $ | 196,589 | ||||||||||
| Supplemental disclosures of cash flow information: | ||||||||||||||
| Cash paid-interest | $ | 59,775 | $ | 68,476 | ||||||||||
| Cash paid-income taxes | 26,413 | 35,938 | ||||||||||||
| Non-cash investing and financing activities: | ||||||||||||||
Accrued and unpaid purchases of property, plant, and equipment | 634 | 4,567 | ||||||||||||
| Equipment financed under finance leases | 3,171 | 1,046 | ||||||||||||
| (Dollars in thousands) | 2025 Consolidated - As Reported | |||||||||||||||||||
| Three months ended | ||||||||||||||||||||
| March 29, 2025 | June 28, 2025 | September 27, 2025 | ||||||||||||||||||
Cost of sales | $ | 115,466 | $ | 141,764 | $ | 119,200 | ||||||||||||||
| Gross profit | 113,375 | 157,839 | 125,136 | |||||||||||||||||
| Selling, general and administrative expense | 65,117 | 71,893 | 69,803 | |||||||||||||||||
| (Dollars in thousands) | 2025 Consolidated - After Change in Presentation (1) | |||||||||||||||||||
| Three months ended | ||||||||||||||||||||
| March 29, 2025 | June 28, 2025 | September 27, 2025 | ||||||||||||||||||
Cost of sales | $ | 123,588 | $ | 152,149 | $ | 127,635 | ||||||||||||||
| Gross profit | 105,253 | 147,454 | 116,701 | |||||||||||||||||
| Selling, general and administrative expense | 56,995 | 61,508 | 61,368 | |||||||||||||||||
| (Dollars in thousands) | 2024 Consolidated - As Reported | |||||||||||||||||||||||||
| Three months ended | ||||||||||||||||||||||||||
| March 30, 2024 | June 29, 2024 | September 28, 2024 | December 31, 2024 | |||||||||||||||||||||||
Cost of sales | $ | 107,990 | $ | 139,306 | $ | 114,474 | $ | 159,079 | ||||||||||||||||||
| Gross profit | 104,579 | 145,087 | 113,095 | 167,996 | ||||||||||||||||||||||
| Selling, general and administrative expense | 60,014 | 63,155 | 64,509 | 73,250 | ||||||||||||||||||||||
| (Dollars in thousands) | 2024 Consolidated - After Change in Presentation | |||||||||||||||||||||||||
| Three months ended | ||||||||||||||||||||||||||
| March 30, 2024 | June 29, 2024 | September 28, 2024 | December 31, 2024 | |||||||||||||||||||||||
Cost of sales | $ | 116,210 | $ | 150,971 | $ | 123,668 | $ | 173,781 | ||||||||||||||||||
| Gross profit | 96,359 | 133,422 | 103,901 | 153,294 | ||||||||||||||||||||||
| Selling, general and administrative expense | 51,794 | 51,490 | 55,315 | 58,548 | ||||||||||||||||||||||
| (Dollars in thousands) | 2025 North America - As Reported | |||||||||||||||||||
| Three months ended | ||||||||||||||||||||
| March 29, 2025 | June 28, 2025 | September 27, 2025 | ||||||||||||||||||
Cost of sales | $ | 88,333 | $ | 114,615 | $ | 98,223 | ||||||||||||||
| Segment selling, general and administrative expense | 49,625 | 51,390 | 47,831 | |||||||||||||||||
| (Dollars in thousands) | 2025 North America - After Change in Presentation (1) | |||||||||||||||||||
| Three months ended | ||||||||||||||||||||
| March 29, 2025 | June 28, 2025 | September 27, 2025 | ||||||||||||||||||
Cost of sales | $ | 95,826 | $ | 124,335 | $ | 106,141 | ||||||||||||||
| Segment selling, general and administrative expense | 42,132 | 41,670 | 39,913 | |||||||||||||||||
| (Dollars in thousands) | 2024 North America - As Reported | |||||||||||||||||||||||||
| Three months ended | ||||||||||||||||||||||||||
| March 30, 2024 | June 29, 2024 | September 28, 2024 | December 31, 2024 | |||||||||||||||||||||||
Cost of sales | $ | 83,552 | $ | 113,683 | $ | 93,092 | $ | 130,896 | ||||||||||||||||||
| Segment selling, general and administrative expense | 44,161 | 46,325 | 44,200 | 53,335 | ||||||||||||||||||||||
| (Dollars in thousands) | 2024 North America - After Change in Presentation | |||||||||||||||||||||||||
| Three months ended | ||||||||||||||||||||||||||
| March 30, 2024 | June 29, 2024 | September 28, 2024 | December 31, 2024 | |||||||||||||||||||||||
Cost of sales | $ | 91,069 | $ | 124,488 | $ | 101,695 | $ | 144,972 | ||||||||||||||||||
| Segment selling, general and administrative expense | 36,644 | 35,520 | 35,597 | 39,259 | ||||||||||||||||||||||
| (Dollars in thousands) | 2025 Europe & Rest of World - As Reported | |||||||||||||||||||
| Three months ended | ||||||||||||||||||||
| March 29, 2025 | June 28, 2025 | September 27, 2025 | ||||||||||||||||||
Cost of sales | $ | 27,133 | $ | 27,149 | $ | 20,977 | ||||||||||||||
| Segment selling, general and administrative expense | 7,772 | 9,358 | 8,549 | |||||||||||||||||
| (Dollars in thousands) | 2025 Europe & Rest of World - After Change in Presentation (1) | |||||||||||||||||||
| Three months ended | ||||||||||||||||||||
| March 29, 2025 | June 28, 2025 | September 27, 2025 | ||||||||||||||||||
Cost of sales | $ | 27,762 | $ | 27,814 | $ | 21,494 | ||||||||||||||
| Segment selling, general and administrative expense | 7,143 | 8,693 | 8,032 | |||||||||||||||||
| (Dollars in thousands) | 2024 Europe & Rest of World - As Reported | |||||||||||||||||||||||||
| Three months ended | ||||||||||||||||||||||||||
| March 30, 2024 | June 29, 2024 | September 28, 2024 | December 31, 2024 | |||||||||||||||||||||||
Cost of sales | $ | 24,438 | $ | 25,623 | $ | 21,382 | $ | 28,183 | ||||||||||||||||||
| Segment selling, general and administrative expense | 8,338 | 9,019 | 8,402 | 7,832 | ||||||||||||||||||||||
| (Dollars in thousands) | 2024 Europe & Rest of World - After Change in Presentation | |||||||||||||||||||||||||
| Three months ended | ||||||||||||||||||||||||||
| March 30, 2024 | June 29, 2024 | September 28, 2024 | December 31, 2024 | |||||||||||||||||||||||
Cost of sales | $ | 25,141 | $ | 26,483 | $ | 21,973 | $ | 28,809 | ||||||||||||||||||
| Segment selling, general and administrative expense | 7,635 | 8,159 | 7,811 | 7,206 | ||||||||||||||||||||||
| (Dollars in thousands) | Three Months Ended | Year Ended | ||||||||||||||||||||||||
| December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||
| Net income | $ | 68,410 | $ | 54,733 | $ | 151,570 | $ | 118,655 | ||||||||||||||||||
| Depreciation | 5,809 | 6,149 | 22,835 | 20,078 | ||||||||||||||||||||||
| Amortization | 8,643 | 9,484 | 34,451 | 35,783 | ||||||||||||||||||||||
| Interest expense, net | 11,665 | 13,563 | 50,282 | 62,163 | ||||||||||||||||||||||
| Income taxes | 6,901 | 8,686 | 33,067 | 25,527 | ||||||||||||||||||||||
| Loss on debt extinguishment | — | — | — | 4,926 | ||||||||||||||||||||||
| EBITDA | 101,428 | 92,615 | 292,205 | 267,132 | ||||||||||||||||||||||
Stock-based compensation (a) | — | 52 | 57 | 608 | ||||||||||||||||||||||
Currency exchange items (b) | (159) | (366) | 79 | (836) | ||||||||||||||||||||||
Acquisition and restructuring related expense, net (c) | 119 | 3,976 | 3,886 | 6,464 | ||||||||||||||||||||||
Other (d) | 1,487 | 2,422 | 3,052 | 4,079 | ||||||||||||||||||||||
| Total Adjustments | 1,447 | 6,084 | 7,074 | 10,315 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 102,875 | $ | 98,699 | $ | 299,279 | $ | 277,447 | ||||||||||||||||||
| Net income margin | 19.6 | % | 16.7 | % | 13.5 | % | 11.3 | % | ||||||||||||||||||
| Adjusted EBITDA margin | 29.4 | % | 30.2 | % | 26.7 | % | 26.4 | % | ||||||||||||||||||
| (a) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of Hayward’s initial public offering (the “IPO”). | |||||||
| (b) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
| (c) | Adjustments in the fiscal quarter ended December 31, 2025 are primarily driven by $0.1 million of costs related to transaction costs for an asset acquisition closed during the fourth quarter. Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by $2.9 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow was released to the specified key employees if such employees were employed by Hayward on the one-year anniversary of the acquisition. These payments were contingent on continued employment and were not dependent on the achievement of any metric or performance measure. The retention costs were recognized over the 12-month period from the date of acquisition. Additionally, there were $0.9 million of termination benefits related to a reduction-in-force within E&RW and $0.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business. | |||||||
Adjustments in the year ended December 31, 2025 are primarily driven by $3.1 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition pursuant to the conditions in the acquisition agreement discussed above. Other adjustments for the year ended December 31, 2025 include $0.4 million of costs related to restructuring actions in E&RW, $0.3 million of separation costs for the consolidation of operations in North America and $0.2 million of other acquisition and integration costs, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, North Carolina from Berkeley Heights, New Jersey. Adjustments in the year ended December 31, 2024 are primarily driven by $3.2 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition pursuant to the conditions in the acquisition agreement discussed above. Other adjustments for the year ended December 31, 2024 include $1.1 million of transaction and integration costs associated with the acquisition for the ChlorKing business, $0.9 million of termination benefits related to a reduction-in-force within E&RW, $0.8 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.4 million of costs to finalize restructuring actions initiated in prior years. | ||||||||
| (d) | Adjustments in the fiscal quarter ended December 31, 2025 are driven by $1.5 million for the settlement in principle of the securities class action litigation. Additional expenses will be paid by the Company's insurance carriers pursuant to the Company's retention amount with its insurance carriers. Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by a $1.6 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility. | |||||||
Adjustments in the year ended December 31, 2025 primarily include $4.3 million for the settlement in principle of the securities class action litigation. Expenses beyond the $4.3 million related to this case are subject to insurance recoveries pursuant to the Company’s retention amount with its insurance carriers. Other adjustments include $1.3 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the year ended December 31, 2024 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility and $0.5 million of costs incurred related to litigation, partially offset by $0.5 million of gains on the sale of assets. | ||||||||
| (Dollars in thousands, except per share data) | Three Months Ended | Year Ended | ||||||||||||||||||||||||
| December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||
| Net income | $ | 68,410 | $ | 54,733 | $ | 151,570 | $ | 118,655 | ||||||||||||||||||
Tax adjustments (a) | (11,697) | (7,167) | (12,369) | (9,389) | ||||||||||||||||||||||
| Other adjustments and amortization: | ||||||||||||||||||||||||||
Stock-based compensation (b) | — | 52 | 57 | 608 | ||||||||||||||||||||||
Currency exchange items (c) | (159) | (366) | 79 | (836) | ||||||||||||||||||||||
Acquisition and restructuring related expense, net (d) | 119 | 3,976 | 3,886 | 6,464 | ||||||||||||||||||||||
Other (e) | 1,487 | 2,422 | 3,052 | 4,079 | ||||||||||||||||||||||
| Total other adjustments | 1,447 | 6,084 | 7,074 | 10,315 | ||||||||||||||||||||||
| Loss on debt extinguishment | — | — | — | 4,926 | ||||||||||||||||||||||
| Amortization | 8,643 | 9,484 | 34,451 | 35,783 | ||||||||||||||||||||||
Tax effect (f) | (2,492) | (3,892) | (10,219) | (12,356) | ||||||||||||||||||||||
| Adjusted net income | $ | 64,311 | $ | 59,242 | $ | 170,507 | $ | 147,934 | ||||||||||||||||||
| Weighted average number of common shares outstanding, basic | 217,159,379 | 215,584,373 | 216,593,972 | 215,028,683 | ||||||||||||||||||||||
| Weighted average number of common shares outstanding, diluted | 222,531,701 | 221,872,482 | 222,225,777 | 221,370,188 | ||||||||||||||||||||||
| Basic EPS | $ | 0.32 | $ | 0.25 | $ | 0.70 | $ | 0.55 | ||||||||||||||||||
| Diluted EPS | $ | 0.31 | $ | 0.25 | $ | 0.68 | $ | 0.54 | ||||||||||||||||||
| Adjusted basic EPS | $ | 0.30 | $ | 0.27 | $ | 0.79 | $ | 0.69 | ||||||||||||||||||
| Adjusted diluted EPS | $ | 0.29 | $ | 0.27 | $ | 0.77 | $ | 0.67 | ||||||||||||||||||
| (a) | Tax adjustments for the three and twelve months ended December 31, 2025 reflect a normalized tax rate of 24.7% and 24.6%, respectively, compared to the Company’s effective tax rate of 9.2% and 17.9%, respectively. The Company’s effective tax rate for the three and twelve months ended December 31, 2025 is primarily driven by a decrease in the applicable state tax rate on certain deferred income. Tax adjustments for the three and twelve months ended December 31, 2024 reflect a normalized tax rate of 25% and 24.2%, respectively, compared to the Company's effective tax rate of 13.7% and 17.7%, respectively. The Company’s effective tax rate for the three and twelve months ended December 31, 2024 primarily includes the tax benefits resulting from prior period return-to-provision adjustments, revaluation of deferred tax liabilities as a result of state tax changes, and the exercise of stock options along with other miscellaneous items. | |||||||
| (b) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO. | |||||||
| (c) | Represents unrealized non-cash (gains) losses on foreign denominated monetary assets and liabilities and foreign currency contracts. | |||||||
| (d) | Adjustments in the fiscal quarter ended December 31, 2025 are primarily driven by $0.1 million of costs related to transaction costs for an asset acquisition closed during the fourth quarter. Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by $2.9 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition. Pursuant to the ChlorKing acquisition agreement, this $3.2 million was part of a total $6.3 million employee retention payment that was deposited into an escrow account on the date of acquisition. The full amount held in escrow was released to the specified key employees if such employees were employed by Hayward on the one-year anniversary of the acquisition. These payments were contingent on continued employment and were not dependent on the achievement of any metric or performance measure. The retention costs were recognized over the 12-month period from the date of acquisition. Additionally, there were $0.9 million of termination benefits related to a reduction-in-force within E&RW and $0.1 million of transaction and integration costs associated with the acquisition of the ChlorKing business. | |||||||
| Adjustments in the year ended December 31, 2025 are primarily driven by $3.1 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition pursuant to the conditions in the acquisition agreement discussed above. Other adjustments for the year ended December 31, 2025 include $0.4 million of costs related to restructuring actions in E&RW, $0.3 million of separation costs for the consolidation of operations in North America and $0.2 million of other acquisition and integration costs, partially offset by a reduction in expense of $0.2 million to finalize the relocation of the Company's corporate office functions to Charlotte, North Carolina from Berkeley Heights, New Jersey. Adjustments in the year ended December 31, 2024 are primarily driven by $3.2 million of compensation expenses for the retention of key employees acquired in the ChlorKing acquisition pursuant to the conditions in the acquisition agreement discussed above. Other adjustments for the year ended December 31, 2024 include $1.1 million of transaction and integration costs associated with the acquisition for the ChlorKing business, $0.9 million of termination benefits related to a reduction-in-force within E&RW, $0.8 million of separation and other costs associated with the centralization and consolidation of operations in Europe and $0.4 million of costs to finalize restructuring actions initiated in prior years. | ||||||||
| (e) | Adjustments in the fiscal quarter ended December 31, 2025 are driven by $1.5 million for the settlement in principle of the securities class action litigation. Additional expenses will be paid by the Company's insurance carriers pursuant to the Company's retention amount with its insurance carriers. Adjustments in the fiscal quarter ended December 31, 2024 are primarily driven by a $1.6 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility. | |||||||
| Adjustments in the year ended December 31, 2025 primarily include $4.3 million for the settlement in principle of the securities class action litigation. Expenses beyond the $4.3 million related to this case are subject to insurance recoveries pursuant to the Company’s retention amount with its insurance carriers. Other adjustments include $1.3 million of income from insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the year ended December 31, 2024 are primarily driven by a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business, $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility and $0.5 million of costs incurred related to litigation, partially offset by $0.5 million of gains on the sale of assets. | ||||||||
| (f) | The tax effect represents the immediately preceding adjustments at the normalized tax rates as discussed in footnote (a) above. | |||||||
| (Dollars in thousands) | Three Months Ended | Three Months Ended | ||||||||||||||||||||||||
| December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||
| NAM | E&RW | NAM | E&RW | |||||||||||||||||||||||
| Segment income | $ | 102,543 | $ | 6,166 | $ | 95,089 | $ | 4,832 | ||||||||||||||||||
| Depreciation | 4,917 | 467 | 5,370 | 424 | ||||||||||||||||||||||
| Amortization | 1,769 | — | 2,111 | — | ||||||||||||||||||||||
Other (a) | 6 | — | 2,356 | — | ||||||||||||||||||||||
| Total adjustments | 6,692 | 467 | 9,837 | 424 | ||||||||||||||||||||||
| Adjusted segment income | $ | 109,235 | $ | 6,633 | $ | 104,926 | $ | 5,256 | ||||||||||||||||||
| Segment income margin % | 33.2 | % | 15.1 | % | 33.2 | % | 11.8 | % | ||||||||||||||||||
| Adjusted segment income margin % | 35.4 | % | 16.3 | % | 36.7 | % | 12.8 | % | ||||||||||||||||||
| (a) | Adjustments in the fiscal quarter ended December 31, 2025 for NAM represent losses on the sale of assets. Adjustments in the fiscal quarter ended December 31, 2024 for NAM are primarily driven by a $1.6 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs sustained from flood damage associated with a hurricane at a contract manufacturing facility. | |||||||
| (Dollars in thousands) | Year Ended | Year Ended | ||||||||||||||||||||||||
| December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||
| NAM | E&RW | NAM | E&RW | |||||||||||||||||||||||
| Segment income | $ | 284,758 | $ | 26,540 | $ | 261,735 | $ | 21,632 | ||||||||||||||||||
| Depreciation | 19,540 | 1,761 | 17,989 | 1,215 | ||||||||||||||||||||||
| Amortization | 6,990 | — | 6,985 | — | ||||||||||||||||||||||
Stock-based compensation (a) | — | — | 176 | 10 | ||||||||||||||||||||||
Other (b) | (605) | — | 4,079 | — | ||||||||||||||||||||||
| Total adjustments | 25,925 | 1,761 | 29,229 | 1,225 | ||||||||||||||||||||||
Adjusted segment income | $ | 310,683 | $ | 28,301 | $ | 290,964 | $ | 22,857 | ||||||||||||||||||
| Segment income margin % | 29.7 | % | 16.3 | % | 29.2 | % | 13.9 | % | ||||||||||||||||||
Adjusted segment income margin % | 32.4 | % | 17.4 | % | 32.5 | % | 14.6 | % | ||||||||||||||||||
| (a) | Represents non-cash stock-based compensation expense related to equity awards issued to management, employees, and directors. The adjustment includes only expense related to awards issued under the 2017 Equity Incentive Plan, which were awards granted prior to the effective date of the IPO. | |||||||
| (b) | Adjustments in the year ended December 31, 2025 for NAM primarily includes $0.6 million of insurance proceeds related to flood damage associated with a hurricane at a contract manufacturing facility. Adjustments in the year ended December 31, 2024 for NAM include a $3.3 million increase in cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of the ChlorKing business and $0.7 million of costs related to a flood sustained at a contract manufacturer. | |||||||